Cargando…
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
Despite the significant resources dedicated to the development of monoclonal antibody (mAb) therapies for solid tumors, the clinical success, thus far, has been modest. Limited efficacy of mAb in solid tumors likely relates to unique aspects of tumor physiology. Solid tumors have an aberrant vascula...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330533/ https://www.ncbi.nlm.nih.gov/pubmed/35979855 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0704 |